IRIS
FONTI, ROSA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.293
EU - Europa 1.670
NA - Nord America 1.659
SA - Sud America 275
AF - Africa 90
OC - Oceania 5
Totale 5.992
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.586
SG - Singapore 1.328
RU - Federazione Russa 900
CN - Cina 504
IT - Italia 257
BR - Brasile 219
HK - Hong Kong 201
VN - Vietnam 141
DE - Germania 95
FI - Finlandia 60
IE - Irlanda 57
UA - Ucraina 47
CI - Costa d'Avorio 43
GB - Regno Unito 43
NL - Olanda 43
BE - Belgio 42
CA - Canada 40
SE - Svezia 33
KR - Corea 22
AR - Argentina 21
IN - India 20
FR - Francia 17
MX - Messico 16
ZA - Sudafrica 14
AT - Austria 13
PL - Polonia 13
LT - Lituania 12
EC - Ecuador 11
IQ - Iraq 10
ES - Italia 9
CO - Colombia 8
TR - Turchia 8
BD - Bangladesh 7
PY - Paraguay 7
JP - Giappone 6
DO - Repubblica Dominicana 5
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
ID - Indonesia 4
PH - Filippine 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
CL - Cile 3
CZ - Repubblica Ceca 3
IR - Iran 3
IS - Islanda 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
AO - Angola 2
AU - Australia 2
BG - Bulgaria 2
BW - Botswana 2
CG - Congo 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
NZ - Nuova Zelanda 2
PA - Panama 2
PK - Pakistan 2
RO - Romania 2
RS - Serbia 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
CR - Costa Rica 1
CV - Capo Verde 1
DM - Dominica 1
GH - Ghana 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PS - Palestinian Territory 1
Totale 5.987
Salva come PNG Salva come JPEG
Città #
Singapore 642
Moscow 226
Chandler 212
Hong Kong 199
Beijing 157
Ashburn 108
Santa Clara 89
Hefei 87
Naples 80
Millbury 60
Jacksonville 55
Boston 47
Princeton 47
Ho Chi Minh City 46
Los Angeles 45
Nanjing 38
Brussels 37
Amsterdam 36
Munich 31
New York 31
Redondo Beach 30
Hanoi 28
The Dalles 27
Woodbridge 27
Buffalo 26
Des Moines 25
Napoli 22
Ottawa 20
Seoul 20
Wilmington 20
Seattle 19
Tianjin 17
Dallas 16
Dublin 15
Nuremberg 15
São Paulo 15
Milan 14
Chicago 13
Lawrence 13
Changsha 12
Hebei 12
Nanchang 12
Da Nang 11
Orem 10
San Francisco 10
London 9
Shenyang 9
Biên Hòa 8
Brooklyn 8
Denver 8
Frankfurt am Main 8
Helsinki 8
Mexico City 8
Poplar 8
Warsaw 8
Atlanta 7
Falls Church 7
Houston 7
Kochi 7
Montreal 7
Stockholm 7
Turku 7
Boardman 6
Dong Ket 6
Falkenstein 6
Haiphong 6
Kronberg 6
Phoenix 6
Tokyo 6
Vienna 6
Brescia 5
Caserta 5
Dearborn 5
Hải Dương 5
Norwalk 5
Baku 4
Charlotte 4
Chennai 4
Courcelles 4
Curitiba 4
Jiaxing 4
Lappeenranta 4
Rio de Janeiro 4
Santo Domingo 4
Sorocaba 4
Uberlândia 4
Wroclaw 4
Zhengzhou 4
Ankara 3
Asunción 3
Baghdad 3
Belo Horizonte 3
Bexley 3
Bratislava 3
Campinas 3
Casal di Principe 3
Dakar 3
Erbil 3
Giugliano in Campania 3
Hangzhou 3
Totale 3.014
Salva come PNG Salva come JPEG
Nome #
2-deoxy-2[F-18] fluoro-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma 156
Machine Learning and Texture Analysis of [18F]FDG PET/CT Images for the Prediction of Distant Metastases in Non-Small-Cell Lung Cancer Patients 131
Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors. 127
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 125
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma 119
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 115
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis 113
Heterogeneity of SSTR2 expression assessed by 68Ga-DOTATOC PET/CT using coefficient of variation in patients with neuroendocrine tumors 110
Heterogeneity of glycolytic phenotype determined by 18F-FDG PET/CT using coefficient of variation in patients with advanced non-small cell lung cancer 106
Coefficient of variation in metastatic lymph nodes determined by 18F-FDG PET/CT in patients with advanced NSCLC: combination with coefficient of variation in primary tumors 104
Washout of 99mTc-Sestamibi in predicting response to chemotherapy in patients with multiple myeloma. 104
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma 100
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study 99
Neutrophil extracellular traps as an adhesion substrate for different tumor cells expressing RGD-binding integrins. 98
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study 98
Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors 97
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients 96
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study 93
Multimodal imaging with 18F-FDG-PET/CT and 111In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma 93
Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer 92
Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma 92
Non-canonical role of PDK1 as a negative regulator of apoptosis through macromolecular complexes assembly at the ER-mitochondria interface in oncogene-driven NSCLC 91
Functional imaging of multidrug resistance in breast cancer. 89
Nuclear imaging in cancer theranostic 88
Bone scintigraphy and SPECT/CT in bisphosphonate-induced osteonecrosis of the jaw 88
PET/CT in cancer research: from preclinical to clinical applications. 86
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcima 84
99mTc-MIBI in the evaluation of breast cancer biology 84
Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma 84
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. 83
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the evaluation of patients with multiple myeloma 83
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. 83
Oncologia 82
Carcinoide timico in paziente affetta da sindrome da neoplasie endocrine multiple di tipo 1 (MEN1): ruolo dello screening radiologico e medico-nucleare 81
Brain metastases unresponsive to immunotherapy detected by 18F-FDG-PET/CT in a patient with melanoma 81
Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1) 80
A Survey of surgical Pathology of the medistinum preliminary data from a multicenter study”. 79
Metabolic tumor volume assessed by 18F-FDG-PET/CT for the prediction of outcome in patients with multiple myeloma 79
Detection of leptomeningeal involvement by 18F-FDG-PET/CT in a patient with non-Hodgkin lymphoma 79
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3. 78
Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients 77
Preclinical imaging in targeted cancer therapies. 76
99mTc-MIBI uptake in breast cancer cells during early phases of apoptosis induction with Staurosporine 76
99mTc-MIBI uptake in Bcl-2 overexpressing non-Hodgkin's lymphoma patients during drug-induced apoptosis. 76
F-18-FDG-PET/CT, 99mTC-MIBI and MRI in the evaluation of patients with multiple myeloma 76
Combined imaging with 18F-FDG-PET/CT and 111In-labeled Octreotide SPECT for evaluation of thymic epithelial tumors 76
A look into the future: the role of PSMA beyond prostate cancer 75
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma 75
18F-FDG-PET/CT in the evaluation of bone marrow infiltration in patients with multiple myeloma. 72
Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy. 71
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma 70
What molecular imaging of cancer patients can teach us about COVID-19 67
Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. 65
Coordinate modulation of glycolytic enzymes and OXPHOS by imatinib in BCR-ABL driven chronic myelogenous leukemia cells. 65
PET-based volumetric biomarkers for risk stratification of non-small cell lung cancer patients 65
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography. 64
SPECT imaging of endoplasmic reticulum-mediated tumor response to gefitinib and erlotinib in lung cancer 64
In vitro receptor imaging for characterization of human solid tumors. 63
Evidence of brown fat activity in constitutional leanness. 63
A reversible shift of driver dependence from EGFR to Notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors. 62
Metabolic Tumor Volume assessed by 18F-FDG-PET/CT in the evaluation of plasma cell mass and prediction of outcome in patients with multiple myeloma. 60
Molecular Imaging of drug resistance in cancer. 59
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy 59
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography 55
PET/CT in radiation oncology 55
Preclinical imaging for targeting cancer immune evasion 53
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay 52
Imaging of immunotherapy response in non-small cell lung cancer: challenges and perspectives. 52
Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non-small cell lung cancer. 51
Ig antibody levels to Helicobacter pylori and histology of antral gastritis and duodenal ulcer: What is the correlation? 45
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography 45
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors 41
Sentinel lymph node identification in breast cancer patients 41
Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by 18F-Fluorothymidine 39
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 36
Metastasis to the Sellar/Suprasellar Region in a Patient with Endometrial Carcinoma Detected by 18F-FDG PET/CT 28
Texture Analysis of 68Ga-DOTATOC PET/CT Images for the Prediction of Outcome in Patients with Neuroendocrine Tumors 27
Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers 22
Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy 18
Prognostic Value of Tumor Dissemination (Dmax) Derived from Basal 18F-FDG Positron Emission Tomography/Computed Tomography in Patients with Advanced Non-Small-Cell Lung Cancer 15
Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin–bleomycin–vinblastine–dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study 15
Totale 6.116
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.054
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 25 12 4 19 5 9 8
2021/2022346 7 1 7 1 7 9 6 7 48 14 88 151
2022/2023473 65 48 11 35 66 57 3 56 67 34 26 5
2023/2024359 16 42 39 23 23 15 19 71 14 13 57 27
2024/20251.963 101 113 6 19 49 100 235 137 113 217 715 158
2025/20262.436 379 288 401 392 841 135 0 0 0 0 0 0
Totale 6.116